drugset / Trial / NCT02557490
Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study was a randomized controlled trial to compare the effect of oxaliplatin and raltitrexed treatment of colorectal cancer with liver metastases by TACE hepatic artery infusion
Timeline
- Start
- 2015-01
- Primary completion
- 2016-12
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxaliplatin | Small molecule | 130 mg/m2 | Other |
| Subject | Raltitrexed | Small molecule | 3 mg/m2 | Other |